4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-21-009169
President and CEO sold 50,000 shares at an average $40.09 ($2,004,390)
- President and CEO acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Torley Helen · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-04 | Exercise or conversion : show line 1 in the form | +50,000 | $14.66 | $733,000 | 587,160 | D |
| 2021-10-04 | Sale : show line 2 in the form | −44,143 | $39.97 | $1,764,528 | 543,017 | D |
| 2021-10-04 | Sale : show line 3 in the form | −5,857 | $40.95 | $239,862 | 537,160 | D |
| Open-market sales · 50,000 sh · avg $40.09 · $2,004,390 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2021-10-04 | Exercise or conversion : show line 4 in the form Option to Purchase Common Stock | −50,000 | $14.66 | $733,000 | $14.66 | 2024-01-06 | 50,000 | 200,000 | D |
Loading xslF345X03/edgar.xml…